13G/A filed by Bain Capital Life Sciences Opportunities III, LP
Bain Capital Life Sciences Opportunities III, LP reported 21,209,188 CABA shares, 9.57% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 12:00:02 UTC.
- Accession
- 0001193125-26-461980
- Filer
- CIK 1950105
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- CABA · CABALETTA BIO, INC.
- Shares
- 21,209,188
- Percent of class
- 9.57%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Read for the filer group Bain Capital Life Sciences Investors, LLC.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Opportunities III, LP | PN | 0 | 21,209,188 | 0 | 21,209,188 | 21,209,188 | 9.57% |